Linical Co., Ltd. (2183.T)
JPY 294.0
(2.8%)
JPY 294.0
(2.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.24 Billion JPY | -31.25% |
| 2022 | 1.89 Billion JPY | 11.54% |
| 2021 | 1.5 Billion JPY | 58.8% |
| 2020 | 801.38 Million JPY | -27.28% |
| 2019 | 1.28 Billion JPY | -18.3% |
| 2018 | 1.62 Billion JPY | -15.78% |
| 2017 | 2.04 Billion JPY | -10.09% |
| 2016 | 2.21 Billion JPY | 3.86% |
| 2015 | 2.18 Billion JPY | 136.45% |
| 2014 | 828.79 Million JPY | 28.53% |
| 2013 | 724.35 Million JPY | -29.52% |
| 2012 | 1.02 Billion JPY | 35.42% |
| 2011 | 758.92 Million JPY | 140.31% |
| 2010 | 314.5 Million JPY | -37.01% |
| 2009 | 501.92 Million JPY | -6.25% |
| 2008 | 532.6 Million JPY | 7.48% |
| 2007 | 503.49 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 63.25 Million JPY | -55.99% |
| 2023 Q1 | 174.73 Million JPY | -66.14% |
| 2023 Q3 | 350.74 Million JPY | 6.71% |
| 2023 FY | - JPY | -31.25% |
| 2023 Q4 | 218.82 Million JPY | -37.61% |
| 2023 Q2 | 328.67 Million JPY | 88.1% |
| 2022 FY | - JPY | 11.54% |
| 2022 Q4 | 516 Million JPY | 219.85% |
| 2022 Q3 | 161.32 Million JPY | -70.12% |
| 2022 Q2 | 539.94 Million JPY | 456.91% |
| 2022 Q1 | 96.95 Million JPY | -70.27% |
| 2021 Q1 | 135.49 Million JPY | -73.7% |
| 2021 Q2 | 368.98 Million JPY | 172.32% |
| 2021 Q3 | 355.36 Million JPY | -3.69% |
| 2021 Q4 | 326.15 Million JPY | -8.22% |
| 2021 FY | - JPY | 58.8% |
| 2020 Q2 | 295.91 Million JPY | 282.46% |
| 2020 Q3 | -47.53 Million JPY | -116.06% |
| 2020 FY | - JPY | -27.28% |
| 2020 Q4 | 515.17 Million JPY | 1183.82% |
| 2020 Q1 | -162.18 Million JPY | -209.15% |
| 2019 Q2 | 444.86 Million JPY | 688.36% |
| 2019 Q1 | 56.42 Million JPY | -75.62% |
| 2019 Q3 | 299.76 Million JPY | -32.62% |
| 2019 Q4 | 148.58 Million JPY | -50.43% |
| 2019 FY | - JPY | -18.3% |
| 2018 FY | - JPY | -15.78% |
| 2018 Q4 | 231.5 Million JPY | -16.86% |
| 2018 Q3 | 278.43 Million JPY | -54.19% |
| 2018 Q2 | 607.85 Million JPY | 281.71% |
| 2018 Q1 | 159.24 Million JPY | -67.62% |
| 2017 Q4 | 491.75 Million JPY | -2.28% |
| 2017 FY | - JPY | -10.09% |
| 2017 Q2 | 583.49 Million JPY | 122.3% |
| 2017 Q3 | 503.22 Million JPY | -13.76% |
| 2017 Q1 | 262.48 Million JPY | -43.61% |
| 2016 FY | - JPY | 3.86% |
| 2016 Q3 | 546.72 Million JPY | -27.4% |
| 2016 Q2 | 753.01 Million JPY | 134.11% |
| 2016 Q4 | 465.47 Million JPY | -14.86% |
| 2016 Q1 | 321.64 Million JPY | -23.64% |
| 2015 FY | - JPY | 136.45% |
| 2015 Q4 | 421.2 Million JPY | -3.16% |
| 2015 Q3 | 434.93 Million JPY | -47.1% |
| 2015 Q2 | 822.19 Million JPY | 156.45% |
| 2015 Q1 | 320.61 Million JPY | -13.25% |
| 2014 FY | - JPY | 28.53% |
| 2014 Q4 | 369.56 Million JPY | 53.85% |
| 2014 Q3 | 240.2 Million JPY | 8.77% |
| 2014 Q2 | 220.83 Million JPY | 128.77% |
| 2014 Q1 | 96.53 Million JPY | -59.06% |
| 2013 Q1 | 86.81 Million JPY | -71.63% |
| 2013 FY | - JPY | -29.52% |
| 2013 Q3 | 170.61 Million JPY | -25.2% |
| 2013 Q4 | 235.8 Million JPY | 38.21% |
| 2013 Q2 | 228.08 Million JPY | 162.73% |
| 2012 Q3 | 181.06 Million JPY | -36.54% |
| 2012 Q1 | 251.05 Million JPY | -8.38% |
| 2012 Q2 | 285.32 Million JPY | 13.65% |
| 2012 Q4 | 306.04 Million JPY | 69.02% |
| 2012 FY | - JPY | 35.42% |
| 2011 FY | - JPY | 140.31% |
| 2011 Q1 | 33.52 Million JPY | -42.45% |
| 2011 Q2 | 247.3 Million JPY | 637.74% |
| 2011 Q3 | 200.94 Million JPY | -18.75% |
| 2011 Q4 | 274.03 Million JPY | 36.38% |
| 2010 FY | - JPY | -37.01% |
| 2010 Q2 | 154.18 Million JPY | 85.9% |
| 2010 Q1 | 82.94 Million JPY | -45.32% |
| 2010 Q3 | 19.12 Million JPY | -87.59% |
| 2010 Q4 | 58.24 Million JPY | 204.51% |
| 2009 Q1 | 216.13 Million JPY | -22.1% |
| 2009 FY | - JPY | -6.25% |
| 2009 Q4 | 151.69 Million JPY | 651.88% |
| 2009 Q3 | -27.48 Million JPY | -117.29% |
| 2009 Q2 | 158.98 Million JPY | -26.44% |
| 2008 Q4 | 277.45 Million JPY | 310.87% |
| 2008 Q2 | 106.39 Million JPY | 0.0% |
| 2008 FY | - JPY | 7.48% |
| 2008 Q3 | 67.53 Million JPY | -36.53% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | -30.177% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | 355.511% |
| GNI Group Ltd. | 14.48 Billion JPY | 91.392% |
| Trans Genic Inc. | 240.95 Million JPY | -417.627% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 191.989% |
| Soiken Holdings Inc. | -583.2 Million JPY | 313.858% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | 306.807% |
| AnGes, Inc. | -8.86 Billion JPY | 114.077% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 197.024% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 116.857% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | -873.587% |
| NanoCarrier Co., Ltd. | -863 Million JPY | 244.523% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 214.238% |
| CanBas Co., Ltd. | 53.65 Million JPY | -2224.715% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | 260.811% |
| RaQualia Pharma Inc. | -111.8 Million JPY | 1215.583% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 202.929% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 190.325% |
| PeptiDream Inc. | 7.37 Billion JPY | 83.091% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 164.634% |
| Ribomic Inc. | -1.01 Billion JPY | 223.18% |
| SanBio Company Limited | -4.52 Billion JPY | 127.563% |
| Healios K.K. | -3 Billion JPY | 141.478% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 206.986% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 189.531% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 188.961% |
| StemRIM | -2.03 Billion JPY | 161.38% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 4.532% |
| FunPep Company Limited | -952 Million JPY | 231.012% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 240.334% |
| Stella Pharma Corporation | -723.85 Million JPY | 272.304% |
| TMS Co., Ltd. | -937 Million JPY | 233.109% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 260.852% |
| Cuorips Inc. | -518 Million JPY | 340.779% |
| K Pharma,Inc. | 366.05 Million JPY | -240.72% |
| Takara Bio Inc. | 8.02 Billion JPY | 84.456% |
| ReproCELL Incorporated | 8.24 Million JPY | -15027.144% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | -1318.309% |
| StemCell Institute Inc. | 534.35 Million JPY | -133.41% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | -409.461% |
| CellSeed Inc. | -836.51 Million JPY | 249.099% |